Female Hormones and the Postmenopausal Endometrium

To the Editor: Whitehead et al. (December 31 issue) showed that the stimulatory effects of unopposed estrogen on the postmenopausal endometrium could be protected against by a six to 10-day course of either norethindrone acetate or D/L-norgestrel. 1 In an earlier article by Hirvonen et al. data were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 1982-06, Vol.306 (23), p.1424-1425
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1425
container_issue 23
container_start_page 1424
container_title The New England journal of medicine
container_volume 306
description To the Editor: Whitehead et al. (December 31 issue) showed that the stimulatory effects of unopposed estrogen on the postmenopausal endometrium could be protected against by a six to 10-day course of either norethindrone acetate or D/L-norgestrel. 1 In an earlier article by Hirvonen et al. data were presented that pointed to the adverse effects of these same two derivatives of 19-nortestosterone on lipid metabolism. 2 Both progestogens caused a reduction in high-density lipoprotein cholesterol and an increase in low-density-lipoprotein cholesterol (although at dosages higher than the minimal level that was demonstrated to be effective by Whitehead et al.), thus increasing the . . . No extract is available for articles shorter than 400 words.
doi_str_mv 10.1056/NEJM198206103062315
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_74044645</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>74044645</sourcerecordid><originalsourceid>FETCH-LOGICAL-c251t-6639ca9808b260ae977dc61bc354b95fe2ce4cee6233e91e9c197a76044123293</originalsourceid><addsrcrecordid>eNp9kDtPw0AQhE8IFELgFyAkVzTIsPf2lShKCCg8Cqit83kjEvl84c4u8u8xSkSF2GaK-Wa0GkIuKdxSkOruZfb0TE3BQFHgoBin8oiMqeQ8FwLUMRkDsCIX2vBTcpbSBoajwozISIMuZCHHhM3R2wazRYg-tJgy29ZZ94nZW0idxzZsbZ9sk83aOnjs4rr35-RkZZuEFwedkI_57H26yJevD4_T-2XumKRdrhQ3zpoCioopsGi0rp2ileNSVEaukDkUDnH4m6OhaBw12moFQlDGmeETcr3v3cbw1WPqSr9ODpvGthj6VGoxoErIAeR70MWQUsRVuY1rb-OupFD-LFX-sdSQujrU95XH-jdzmGbwb_a-96lsceP_bfsGXWZuQQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>74044645</pqid></control><display><type>article</type><title>Female Hormones and the Postmenopausal Endometrium</title><source>MEDLINE</source><source>ProQuest Central UK/Ireland</source><description>To the Editor: Whitehead et al. (December 31 issue) showed that the stimulatory effects of unopposed estrogen on the postmenopausal endometrium could be protected against by a six to 10-day course of either norethindrone acetate or D/L-norgestrel. 1 In an earlier article by Hirvonen et al. data were presented that pointed to the adverse effects of these same two derivatives of 19-nortestosterone on lipid metabolism. 2 Both progestogens caused a reduction in high-density lipoprotein cholesterol and an increase in low-density-lipoprotein cholesterol (although at dosages higher than the minimal level that was demonstrated to be effective by Whitehead et al.), thus increasing the . . . No extract is available for articles shorter than 400 words.</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM198206103062315</identifier><identifier>PMID: 7078585</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Endometrium - drug effects ; Estrogens - adverse effects ; Estrogens - pharmacology ; Female ; Humans ; Menopause - drug effects ; Middle Aged ; Progestins - pharmacology</subject><ispartof>The New England journal of medicine, 1982-06, Vol.306 (23), p.1424-1425</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c251t-6639ca9808b260ae977dc61bc354b95fe2ce4cee6233e91e9c197a76044123293</citedby><cites>FETCH-LOGICAL-c251t-6639ca9808b260ae977dc61bc354b95fe2ce4cee6233e91e9c197a76044123293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,64387</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7078585$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><title>Female Hormones and the Postmenopausal Endometrium</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>To the Editor: Whitehead et al. (December 31 issue) showed that the stimulatory effects of unopposed estrogen on the postmenopausal endometrium could be protected against by a six to 10-day course of either norethindrone acetate or D/L-norgestrel. 1 In an earlier article by Hirvonen et al. data were presented that pointed to the adverse effects of these same two derivatives of 19-nortestosterone on lipid metabolism. 2 Both progestogens caused a reduction in high-density lipoprotein cholesterol and an increase in low-density-lipoprotein cholesterol (although at dosages higher than the minimal level that was demonstrated to be effective by Whitehead et al.), thus increasing the . . . No extract is available for articles shorter than 400 words.</description><subject>Endometrium - drug effects</subject><subject>Estrogens - adverse effects</subject><subject>Estrogens - pharmacology</subject><subject>Female</subject><subject>Humans</subject><subject>Menopause - drug effects</subject><subject>Middle Aged</subject><subject>Progestins - pharmacology</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1982</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kDtPw0AQhE8IFELgFyAkVzTIsPf2lShKCCg8Cqit83kjEvl84c4u8u8xSkSF2GaK-Wa0GkIuKdxSkOruZfb0TE3BQFHgoBin8oiMqeQ8FwLUMRkDsCIX2vBTcpbSBoajwozISIMuZCHHhM3R2wazRYg-tJgy29ZZ94nZW0idxzZsbZ9sk83aOnjs4rr35-RkZZuEFwedkI_57H26yJevD4_T-2XumKRdrhQ3zpoCioopsGi0rp2ileNSVEaukDkUDnH4m6OhaBw12moFQlDGmeETcr3v3cbw1WPqSr9ODpvGthj6VGoxoErIAeR70MWQUsRVuY1rb-OupFD-LFX-sdSQujrU95XH-jdzmGbwb_a-96lsceP_bfsGXWZuQQ</recordid><startdate>19820610</startdate><enddate>19820610</enddate><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19820610</creationdate><title>Female Hormones and the Postmenopausal Endometrium</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c251t-6639ca9808b260ae977dc61bc354b95fe2ce4cee6233e91e9c197a76044123293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1982</creationdate><topic>Endometrium - drug effects</topic><topic>Estrogens - adverse effects</topic><topic>Estrogens - pharmacology</topic><topic>Female</topic><topic>Humans</topic><topic>Menopause - drug effects</topic><topic>Middle Aged</topic><topic>Progestins - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Female Hormones and the Postmenopausal Endometrium</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1982-06-10</date><risdate>1982</risdate><volume>306</volume><issue>23</issue><spage>1424</spage><epage>1425</epage><pages>1424-1425</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>To the Editor: Whitehead et al. (December 31 issue) showed that the stimulatory effects of unopposed estrogen on the postmenopausal endometrium could be protected against by a six to 10-day course of either norethindrone acetate or D/L-norgestrel. 1 In an earlier article by Hirvonen et al. data were presented that pointed to the adverse effects of these same two derivatives of 19-nortestosterone on lipid metabolism. 2 Both progestogens caused a reduction in high-density lipoprotein cholesterol and an increase in low-density-lipoprotein cholesterol (although at dosages higher than the minimal level that was demonstrated to be effective by Whitehead et al.), thus increasing the . . . No extract is available for articles shorter than 400 words.</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>7078585</pmid><doi>10.1056/NEJM198206103062315</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 1982-06, Vol.306 (23), p.1424-1425
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_miscellaneous_74044645
source MEDLINE; ProQuest Central UK/Ireland
subjects Endometrium - drug effects
Estrogens - adverse effects
Estrogens - pharmacology
Female
Humans
Menopause - drug effects
Middle Aged
Progestins - pharmacology
title Female Hormones and the Postmenopausal Endometrium
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T05%3A05%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Female%20Hormones%20and%20the%20Postmenopausal%20Endometrium&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.date=1982-06-10&rft.volume=306&rft.issue=23&rft.spage=1424&rft.epage=1425&rft.pages=1424-1425&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJM198206103062315&rft_dat=%3Cproquest_cross%3E74044645%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=74044645&rft_id=info:pmid/7078585&rfr_iscdi=true